Belatacept Rescue Therapy in the Early Period After Simultaneous Kidney-Pancreas Transplantation
Authors:
Open Access
- 11 April 2024
- journal article
- letter
- Published by Frontiers Media SA in Transplant International
- Vol. 37, 12628
Abstract
Belatacept Rescue Therapy in the Early Period After Simultaneous Kidney-Pancreas TransplantationKeywords
This publication has 8 references indexed in Scilit:
- Challenges of calcineurin inhibitor withdrawal following combined pancreas and kidney transplantation: Results of a prospective, randomized clinical trialAmerican Journal of Transplantation, 2020
- Belatacept rescue for delayed kidney allograft function in a patient with previous combined heart-liver transplantAmerican Journal of Transplantation, 2018
- Early post-transplant conversion from tacrolimus to belatacept for prolonged delayed graft function improves renal function in kidney transplant recipientsClinical Transplantation, 2017
- Conversion From Tacrolimus to Belatacept to Prevent the Progression of Chronic Kidney Disease in Pancreas Transplantation: Case Report of Two PatientsAmerican Journal of Transplantation, 2014
- Switching from Calcineurin Inhibitor-based Regimens to a Belatacept-based Regimen in Renal Transplant RecipientsClinical Journal of the American Society of Nephrology, 2011
- Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT‐EXT Study)American Journal of Transplantation, 2010
- A Phase III Study of Belatacept‐based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)American Journal of Transplantation, 2010
- Diabetic GastroparesisDrugs, 2009